Controlled Drug Delivery Systems

Emmanuel Opara

$336

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press
16 March 2020

Medical research; Nanotechnology; Biotechnology; Pharmaceutical technology

This book will describe current research on drug delivery systems that encompass four broad categories, namely: routes of delivery, delivery vehicles, payload, and targeting strategies. Where appropriate delivery vehicles and relevant release of specific agents in any of these categories in clinical application will be discussed. All chapters will highlight the translational aspects of the various technologies discussed and will provide insights into the advantages of such delivery systems over current ones in clinical or research use. Each technology reviewed in this book will have significant potential to improve patients' lives by enhancing the therapeutic efficacy of drugs.

This book:

Discusses the various factors that mitigate effective oral insulin delivery and the current status of research efforts to overcome these barriers along with recent clinical projections

Examines the advantages and disadvantages of each drug delivery system Examines the standard method of accomplishing controlled drug release through the incorporation of the drugs within polymeric biomaterials such as capsules and microcapsules as well as other vehicles such as liposomes Discusses various controlled drug delivery systems, including sustained release delivery systems and pulse or delayed release, e.g. to target different regions of the gastrointestinal tract. In view of these wide-ranging technological areas, and the up-to-date discussions of opportunities and challenges associated with these applications, the book should provide readers from technology, materials science, pharmacology and clinical disciplines with very valuable information.

Edited by: Emmanuel Opara
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions: Height: 254mm, Width: 178mm,
Weight: 816g
ISBN: 9780367187170
ISBN 10: 0367187175
Pages: 368
Publication Date: 16 March 2020
Audience: College/higher education , Further / Higher Education
Format: Hardback
Publisher's Status: Active

Professor Emmanuel C. Opara earned his PhD in Medical Sciences from the University of London, England. He came to the USA in 1984 as a World Health Organization (WHO) Fellow in Endocrinology/Metabolism at the Mayo Clinic in Rochester, Minnesota. He later moved to the National Institute of Diabetes, Digestive and Kidney diseases (NIDDK) of the National Institutes of Health in Bethesda Maryland, where he served as a Visiting Fellow from 1986 to 1988 prior to accepting a faculty position in the Department of Surgery at Duke University Medical Center, Durham, North Carolina. In 2003, after 15 years at Duke, he was appointed Research Professor at the Pritzker Institute of Biomedical Science and Engineering at the Illinois Institute of Technology (IIT), Chicago while serving as Senior Investigator in the Human Islet Transplant Program at the Pritzker School of Medicine of the University of Chicago. He currently serves as Professor of Regenerative Medicine and Biomedical Engineering at the Wake Forest School of Medicine and the Graduate Program Director at the Wake Forest University Campus of the Joint Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences (SBES).